Vergoeding 2019-2023 voor ATC-subgroep L01BC : Pyrimidinederivaten
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021* | 2022* | 2023* | |
|---|---|---|---|---|---|
| L01BC01 Cytarabine | 291.120 | 287.766 | 305.601 | 267.263 | 269.190 |
| L01BC05 Gemcitabine | 628.331 | 573.159 | 503.419 | 477.468 | 606.883 |
| L01BC06 Capecitabine | 1.793.487 | 1.521.547 | 1.700.598 | 1.352.379 | 1.443.422 |
| L01BC07 Azacitidine | 15.491.888 | 14.511.095 | 7.935.589 | 3.386.826 | 2.417.982 |
| L01BC08 Decitabine | 5.553.019 | 4.283.382 | 3.613.136 | 3.647.623 | 2.636.190 |
| L01BC53 Tegafur combinatiepreparaten | 475.955 | 760.125 | 1.020.108 | 1.117.576 | 1.320.424 |
| L01BC59 Trifluridine combinatiepreparaten | 3.876.484 | 4.110.459 | 3.857.231 | 3.549.915 | 2.745.111 |
| Totaal | 28.110.284 | 26.047.533 | 18.935.681 | 13.799.050 | 11.439.200 |